{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:31:59Z","timestamp":1790289119597,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000525.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000}}],"reference-count":127,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000525.pub3","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T15:20:23Z","timestamp":1334244023000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses"],"prefix":"10.1002","volume":"2013","author":[{"given":"Kaushadh","family":"Jayakody","sequence":"first","affiliation":[{"name":"University of Aberdeen; Applied Health Sciences (Mental Health); Clinical Research Centre, Royal Cornhill Hospital Aberdeen UK AB25 2ZH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Carl","family":"Gibson","sequence":"additional","affiliation":[{"name":"University of the West Indies; Department of Community Health & Psychiatry; Hospital Ring Road University Hospital of the West Indies Mona Kingston 7 Jamaica Kgn 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Leeds and York Partnership NHS Foundation Trust; Psychiatry; Linden House, St Mary's Hospital Green Hill Road Leeds UK LS12 3QE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalmini","family":"Gunadasa","sequence":"additional","affiliation":[{"name":"Department of Health Sciences; Clinicial Trial Unit; The University of York Heslington York UK YO10 5DD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"10.1002\/14651858.CD000525.pub3-BIB0001|cit1","first-page":"44","article-title":"Zuclopenthixol versus haloperidol in the initial treatment of schizophrenic psychoses, affective psychoses and paranoid states; a controlled clinical trial","volume":"7","author":"Al-Haddad","year":"1996","journal-title":"Arab Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0002|cit2","first-page":"35","article-title":"The management of acutely schizophrenic patients newly admitted from the emergency room: a double-blind clinical trial comparing zuclopenthixol acetate and liquid haloperidol","volume-title":"Modern Trends in the Treatment of Chronic Schizophrenia","author":"Chouinard","year":"1991"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004714-199412000-00002","article-title":"A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation","volume":"14","author":"Chouinard","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0004|cit4","first-page":"202","article-title":"Observation of clinical effect of clopixol acuphase injection for acute psychosis","volume":"6","author":"Liu","year":"1997","journal-title":"Chinese Journal of Pharmaco Epidemiology"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0005|cit5","unstructured":"Ropert R Hoepfner Petersen HE Benyay J Where zuclopenthixol acetate stands amid the 'modified release' neuroleptics Congres de Psychiatrie et de Neurologie de Langue Francaise, LXXXVIth Session; 1988 Jun 13-17; Chambery, France 1988 350 62"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0006|cit6","first-page":"365","article-title":"A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics","volume":"53","author":"Chin","year":"1998","journal-title":"Medical Journal of Malaysia"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1993.tb03329.x","article-title":"A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis","volume":"87","author":"Baastrup","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/08039489009096565","article-title":"Zuclopenthixol acetate, haloperidol, and zuclopenthixol in the treatment of acutely psychotic patients - a controlled multicentre study","volume":"44","author":"Fensbo","year":"1990","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0009|cit9","first-page":"4","article-title":"A controlled double blind study of zuclopenthixol acetate compared to clothiapine in acute psychosis including mania and exacerbation of chronic psychosis","volume":"4","author":"Uys","year":"2001","journal-title":"Journal of Depression and Anxiety"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0010|cit10","unstructured":"Uys H Berk M A controlled double blind study of zuclopenthixol acetate compared with clothiapine in acute psychosis including mania and exacerbation of chronic psychosis Proceedings of XXth Collegium Internationale Neuro-psychopharmacologicum, Melbourne, Australia"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1099-1077(199801)13:1<17::AID-HUP937>3.0.CO;2-G","article-title":"A randomized controlled double blind study of zuclopenthixol acetate compared to haloperidol in acute psychosis","volume":"13","author":"Brook","year":"1998","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0012|cit12","first-page":"1301","article-title":"Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychoctic patients","volume":"85","author":"Taymeeyapradit","year":"2002","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00179201","article-title":"Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo","volume":"90","author":"Amdisen","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0447.1987.tb02759.x","article-title":"Zuclopenthixol acetate in Viscoleo - a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses","volume":"75","author":"Amdisen","year":"1987","journal-title":"Acta Psychiatrica Scandinavia"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0015|cit15","first-page":"665","article-title":"Results of a clinical trial of the neuroleptic ciatyl","volume":"12","author":"Anton","year":"1962","journal-title":"Medizinische Welt"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0016|cit16","unstructured":"Arango C Bomb\u00edn I Gonz\u00e1lez-Salvador MT Garc\u00eda-Cabeza I Bobes J Prediction and Prevention of Violence in Schizophrenia Outpatients: Preliminary Report UNPUBLISHED MANUSCRIPT SENT BY THE AUTHORS 2002 68242121"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2007-1014609","article-title":"Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo","volume":"22","author":"Balant","year":"1989","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub3-BIB0018|cit18","first-page":"149","article-title":"A double blind multicentre comparison of oral zuclopenthixol and oral chlorpromazine in the treatment of acute psychosis","author":"Balasubramanian","year":"1991","journal-title":"British Journal of Clinical Research"},{"issue":"9","key":"10.1002\/14651858.CD000525.pub3-BIB0019|cit19","first-page":"473","article-title":"Comprehensive clinical studies with thiothixene","volume":"36","author":"Ban","year":"1975","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0021|cit20","first-page":"47","article-title":"Zuclopenthixol acetate and haloperidol in acute psychotic patients. A randomized multicentre study","volume-title":"New strategies in the treatment of aggressive, acutely psychotic patients","author":"Bobon","year":"1990"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0020|cit21","unstructured":"Bobon D De Bleeker E Zuclopenthixol acetate and haloperidol in acute psychotic patients. A randomized multicentre study Poster, European College of Neuropsychopharmocology Congress, Gothenburg"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0022|cit22","first-page":"236","article-title":"Zuclopenthixol acetate and haloperidol in acute psychoses - results of the AMDP subgroup of a Belgian multicentre study","volume":"87","author":"Bourdouxhe","year":"1987","journal-title":"Acta Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0023|cit23","first-page":"449","article-title":"Improved antisaccade performance with risperidone in schizophrenia","volume":"72","author":"Burke","year":"2002","journal-title":"Journal of Neurology, Psychiatry and Neurosurgery"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1185\/03007999009111492","article-title":"Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients","volume":"12","author":"Chakravarti","year":"1990","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"28\u201331","DOI":"10.1016\/S0924-9338(02)00008-1","article-title":"Zuclopenthixol-acetate treatment in catatonic patients:the implication of iron metabolism","volume":"18","author":"Conca","year":"2003","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0026|cit26","first-page":"169","article-title":"A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population","volume":"10","author":"Dehnel","year":"1968","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0027|cit27","first-page":"34","article-title":"An example of European multicenter trials: multispectral analysis of clozapine","volume":"12","author":"Fischer-Cornelssen","year":"1976","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0028|cit28","unstructured":"Glenthoj BY Mackeprang T Fagerlund B Hemmingsen R Effects of antipsychotics on information-processing and extrastriatal dopamine d2\/d3 receptors in first-episode drug-naive schizophrenic patients 39th Annual Meeting of the American College of Neuropsychopharmacology; 2000; Dec 10-14; San Juan; Puerto Rico 2000"},{"issue":"5","key":"10.1002\/14651858.CD000525.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0447.1978.tb03570.x","article-title":"Cis(Z)-clopenthixol and clopenthixol (Sordinol) in chronic psychotic patients. A double-blind clinical investigation","volume":"58","author":"Gravem","year":"1978","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0030|cit30","first-page":"13","article-title":"Cis(Z)-clopenthixol and clopenthixol in the treatment of acute psychoses and exacerbations of chronic psychoses. A double-blind clinical investigation","volume":"294","author":"Gravem","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"294","key":"10.1002\/14651858.CD000525.pub3-BIB0031|cit31","first-page":"5","article-title":"Cis(Z) clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double blind clinical investigations and other studies with cis(Z) clopenthixol (Cisordinol(R), Clopixol(R))","volume":"64","author":"Gravem","year":"1981","journal-title":"Acta Psychiatrica Scandinavica, Supplementum"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/08039489009096586","article-title":"Co-injection of zuclopenthixol acetate and zuclopenthixol decanoate","volume":"44","author":"Gravem","year":"1990","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0033|cit33","first-page":"25","article-title":"A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients","volume":"294","author":"Heikkila","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0034|cit34","first-page":"30","article-title":"Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients - a double-blind clinical multicentre investigation","volume":"294","author":"Heikkila","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"9","key":"10.1002\/14651858.CD000525.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1185\/03007999209111526","article-title":"Zuclopenthixol and haloperidol in patients with acute psychotic states. A double-blind, multicentre study","volume":"12","author":"Heikkila","year":"1992","journal-title":"Current Medical Research and Opinion"},{"issue":"19","key":"10.1002\/14651858.CD000525.pub3-BIB0036|cit36","first-page":"615","article-title":"Retrospective and prospective studies on the clinical effect of clopenthixol (sordinol) in endogenous phychoses","volume":"97","author":"Hicklin","year":"1967","journal-title":"Schweizerische Medizinische Wochenschrift. Journal Suisse De Medecine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000525.pub3-BIB0037|cit37","first-page":"85s","article-title":"Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes","volume":"9","author":"Huttunen","year":"1994","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0447.1995.tb09781.x","article-title":"Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial","volume":"91","author":"Huttunen","year":"1995","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0039|cit39","first-page":"39","article-title":"Neuroleptic treatment of oligophrenic patients. A double-blind clinical multicentre trial of cis(Z)-clopenthixol and haloperidol","volume":"294","author":"Karsten","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0040|cit40","first-page":"41","article-title":"Double blind study of clopenthixol and chlorpromazine in acute hospitalized schizophrenics","volume":"3","author":"Kingstone","year":"1970","journal-title":"Internationale Zeitschrift Fur Klinische Pharmakologie Therapie und Toxikologie"},{"issue":"3 Suppl.1","key":"10.1002\/14651858.CD000525.pub3-BIB0041|cit41","first-page":"163","article-title":"Sexual dysfunctions and serum prolactin levels in patients using risperidone or quetiapine: a randomised trial","volume":"53","author":"Knegtering","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"512","key":"10.1002\/14651858.CD000525.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1192\/bjp.114.512.833","article-title":"Clopenthixol: a controlled trial in chronic hospitalized schizophrenic patients","volume":"114","author":"Kordas","year":"1968","journal-title":"British Journal of Psychiatry"},{"issue":"1,2","key":"10.1002\/14651858.CD000525.pub3-BIB0043|cit43","first-page":"216","article-title":"Effects of antipsychotics and other agents on prepulse inhibition of the starlte response (PPI)","volume":"49","author":"Kristiansen","year":"2001","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0044|cit44","first-page":"112","article-title":"Thiothixene versus Chlorprothixene versus Clopenthixol","volume":"6","author":"Lehmann","year":"1970","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0045|cit45","first-page":"380","article-title":"Acute psychotic disorders treated with 5% zuclopenthixol acetate in 'Viscoleo' ('Cisordinol-Acutard'), a global assessment of the clinical effect: an open multi-centre study","volume":"5","author":"Lowert","year":"1989","journal-title":"Pharmatherapeutica"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub3-BIB0046|cit46","first-page":"285","article-title":"Atypical versus typical antipsychotic treatment prognosis in first-episode paranoid schizophrenia based on wcst and dichotic listening scores","volume":"11","author":"Loza","year":"2001","journal-title":"European Neuropsychopharmacology (Abstracts of the 14th Congress of the European College of Neuropsychopharmacology; 2001 Oct 13-17; Istanbul, Turkey)"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0924-977X(91)90008-I","article-title":"Zuclopenthixol, a combined dopamine D1\/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia","volume":"1","author":"Lublin","year":"1991","journal-title":"European Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.166.3.374","article-title":"Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients","volume":"166","author":"Malt","year":"1995","journal-title":"British Journal of Psychiatry"},{"issue":"26","key":"10.1002\/14651858.CD000525.pub3-BIB0049|cit49","first-page":"869","article-title":"Rediscovery of a neuroleptic drug in a new form: clopenthixol","volume":"61","author":"Meyers","year":"1972","journal-title":"Schweizerische Rundschau fur Medizin Praxis"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0050|cit50","unstructured":"Moller HJ Huttunen MO The prevalence of extrapyramidal symptoms during short and long term treatment with risperidone 7th Biennial European Winter Workshop on Schizophrenia; 1994 Jan 23-28; Les Diablerets, Switzerland 1994 106 95307869"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0051|cit51","first-page":"215","article-title":"Open clinical study of Clopixol-Acuphase (zuclopenthixol acetate) treatment followed by Clopixol Depot in acute psychoses with long-term course tendency","volume":"29","author":"Predescu","year":"1991","journal-title":"Romanian Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0052|cit52","first-page":"280","article-title":"Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study","volume":"22","author":"Romain","year":"1996","journal-title":"Encephale"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0053|cit53","unstructured":"Saxena B The value of depot neuroleptic injections in the treatment of chronic schizophrenia Schizophrenia 1996 - Breaking down the Barriers. Proceedings of the 4th International Conference; 1996 Oct 6-9; Vancouver, Canada 1996 95307869"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0054|cit54","first-page":"60","article-title":"Zuclopenthixol acetate in viscoleo in acutely disturbed psychotic patients","volume":"28","author":"Schlosberg","year":"1991","journal-title":"Israel Journal of Psychiatry and Related Sciences"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000468256","article-title":"The EEG effects of chemically and clinically dissimilar antipsychotics: molindone vs. chlorpromazine","volume":"6","author":"Serafetinides","year":"1971","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0056|cit56","first-page":"263","article-title":"Psychological effects of single dose antipsychotic medication","volume":"3","author":"Serafetinides","year":"1973","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00005053-197201000-00005","article-title":"Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives","volume":"154","author":"Serafetinides","year":"1972","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-197211000-00010","article-title":"Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia","volume":"5","author":"Serafetinides","year":"1972","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000467995","article-title":"Consistency and similarity of drug EEG responses in chronic schizophrenic patients","volume":"8","author":"Serafetinides","year":"1973","journal-title":"International Pharmacopsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000468000","article-title":"A method of quantifying EEG for psychopharmacological research","volume":"8","author":"Serafetinides","year":"1973","journal-title":"International Pharmacopsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0061|cit61","first-page":"22","article-title":"The Achilles reflex and antipsychotic drugs","volume":"11","author":"Shelton","year":"1969","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00007691-199304000-00007","article-title":"Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients: a single-dose preliminary study","volume":"15","author":"Tan","year":"1993","journal-title":"Therapuetic Drug Monitoring"},{"issue":"11","key":"10.1002\/14651858.CD000525.pub3-BIB0063|cit63","first-page":"1845","article-title":"Advantages of the initial therapy of acute schizophrenia with large doses of droperidol\/A comparative study (author's transl)","volume":"25","author":"Weiser","year":"1975","journal-title":"Arzneimittel Forschung"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/13651500310000906","article-title":"Zuclopenthixol acetate versus haloperidol: An observational randomised pharmacoeconomic evaluation of patients with chronic schizophrenia exhibiting acute psychosis","volume":"7","author":"Lamure","year":"2003","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0065|cit65","unstructured":"Abdullahi AT Gadd EM Treating acute psychiatric illness at home Royal College of Psychiatrists Summer Meeting, Scarborough 1993"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007445.pub2","article-title":"Chlorpromazine for psychosis induced aggression or agitation","author":"Ahmed","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD000525.pub3-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009412","article-title":"Risperidone for psychosis induced aggression or agitation","author":"Ahmed","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0068|cit68","first-page":"1200","article-title":"Detecting skewness from summary information","volume":"31","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1136\/bmj.314.7096.1740","article-title":"ABC of mental health: mental health emergencies","volume":"314","author":"Atakan","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1993.tb03329.x","article-title":"A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis","volume":"87","author":"Baastrup","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0447.1979.tb04484.x","article-title":"The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale: Evaluation of homogeneity and inter-observer reliability","volume":"59","author":"Bech","year":"1979","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub3-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003729.pub2","article-title":"Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses","author":"Belgamwar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0075|cit75","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002304.pub2","article-title":"Clotiapine for acute psychotic illnesses","author":"Carpenter","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001943.pub2","article-title":"Loxapine for schizophrenia","author":"Chakrabarti","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0078|cit78","first-page":"233","article-title":"Extrapyramidal symptom rating scale","volume":"7","author":"Chouninard","year":"1980","journal-title":"Canadian Journal of Neurological Science"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0079|cit79","article-title":"Cochrane Reviewers' Handbook version 4.2.0 [updated March 2003]","volume-title":"The Cochrane Library [database on disk and CDROM]","author":"Clarke","year":"2003"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/bmj.315.7112.884","article-title":"Mental health emergencies","volume":"315","author":"Coutinho","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001164","article-title":"Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses","author":"Coutinho","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0082|cit82","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town Cape Town The Cochrane Collaboration 2000"},{"issue":"6","key":"10.1002\/14651858.CD000525.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"19","key":"10.1002\/14651858.CD000525.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD000525.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003079.pub2","article-title":"Benzodiazepines for psychosis-induced aggression or agitation","author":"Gillies","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD000525.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: Data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0090|cit90","volume-title":"Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology. National Institute of Mental Health Publication No.76-338","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0092|cit92","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","article-title":"The Nurses Observation Scale for Inpatient Evaluation (NOSIE): a new scale for measuring improvement in chronic schizophrenia","volume":"21","author":"Honingfeld","year":"1965","journal-title":"Journal of Clinical Psychology"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub3-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005146.pub2","article-title":"Haloperidol plus promethazine for psychosis-induced aggression","author":"Huf","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Monograph Suppl","key":"10.1002\/14651858.CD000525.pub3-BIB0095|cit95","first-page":"1","article-title":"Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organization ten-country study","volume":"20","author":"Jablensky","year":"1992","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/9780470987353.ch12","article-title":"The epidemiological horizon","volume-title":"Schizophrenia","author":"Jablensky","year":"2003"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/schbul\/19.2.287","article-title":"Psychopharmacologic treatment of schizophrenia","volume":"19","author":"Kane","year":"1993","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0098|cit98","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0099|cit99","unstructured":"Khushu A Powney MJ Adams CE Haloperidol for long term aggression in psychosis Cochrane Database of Systematic Reviews , Issue . Art. No.: . DOI:"},{"issue":"2-3","key":"10.1002\/14651858.CD000525.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"Suppl 334","key":"10.1002\/14651858.CD000525.pub3-BIB0103|cit103","first-page":"100","article-title":"The UKU side effects rating scale. A new comprehensive rating scale for psychotropic drugs and a cross sectional study of side effects in neuroleptic treated patients","volume":"76","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0104|cit104","unstructured":"Lundbeck A pocket guide to clopixol acuphase [promotional material] A pocket guide to clopixol acuphase 1987"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0105|cit105","volume-title":"Product monograph. Clopixol: Clopixol-acuphase: clopixol depot. antipsychotic agent","author":"Lundbeck Canada","year":"2011"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"15","key":"10.1002\/14651858.CD000525.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub3-BIB0109|cit109","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002084.pub2","article-title":"Containment strategies for people with serious mental illness","author":"Muralidharan","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub3-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008074","article-title":"Aripiprazole for psychosis-induced aggression or agitation","author":"Pagadala","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD000525.pub3-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009377","article-title":"Haloperidol (rapid tranquilisation) for psychosis induced aggression or agitation","author":"Powney Melanie","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub3-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001163","article-title":"Seclusion and restraint for people with serious mental illnesses","author":"Sailas","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"Suppl 212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/pb.20.3.149","article-title":"Rapid tranquillisation: A questionnaire survey of practice","volume":"20","author":"Simpson","year":"1996","journal-title":"Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0117|cit117","first-page":"591","article-title":"Prevalence and characteristics of violent patients in a general hospital","volume":"90","author":"Travin","year":"1990","journal-title":"New York State Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD000525.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based intervention in health and health care: A systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0119|cit119","doi-asserted-by":"crossref","unstructured":"Vangala R Ahmed U Ahmed R Loxapine inhaler for psychosis induced aggression or agitation Cochrane Database of Systematic Reviews , Issue . Art. No.: . DOI: 2012","DOI":"10.1002\/14651858.CD010190"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub3-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006391","article-title":"Benzodiazepines for schizophrenia","author":"Volz","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Wilkie F Fenton M Quetiapine for psychosis induced aggression or agitation Cochrane Database of Systematic Reviews , Issue . Art. No.: . DOI: 2012","DOI":"10.1002\/14651858.CD009801"},{"issue":"7","key":"10.1002\/14651858.CD000525.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD000525.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0920-9964(99)00226-1","article-title":"Zuclopenthixol acetate in psychiatric emergencies: looking for evidence from clinical trials","volume":"46","author":"Coutinho","year":"2000","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub3-BIB0124|cit124","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub2","article-title":"Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses","author":"Fenton","year":"1997","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub3-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub2","article-title":"Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses","author":"Fenton","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub3-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub2","article-title":"Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses","author":"Fenton","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub3-BIB0127|cit127","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub2","article-title":"Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses","author":"Gibson","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000525.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000525.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:03:45Z","timestamp":1773619425000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000525.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":127,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000525.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}